Stryker Acquires Amplitude Vascular Systems (AVS) to Add Next-Generation IVL Technology

May 19, 2026

Stryker completed its acquisition of Amplitude Vascular Systems, a privately held medical device company developing a next-generation intravascular lithotripsy (IVL) platform for calcified peripheral arterial disease (PAD). The deal was announced April 13, 2026 and closed May 7, 2026; financial terms were not disclosed in the MedDeviceGuide account, though other sources cite a value of up to $835 million.

Targets
Amplitude Vascular Systems (AVS)
Sellers
BioStar Capital
Industry
Medical Devices
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.